Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brigitte Autran

Showing results (91-100 of 201) with videos related to

Pageof 21
Sort By:
Oncotarget|March 8, 2016
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?Vincent Vieillard, Shahin Gharakhanian, Olivier Lucar, et al.
Presse Medicale (Paris, France : 1983)|May 8, 2012
[The French Committee for the prevention and control of influenza and the 2009 influenza pandemic: Lessons learnt]Jean-Claude Manuguerra, Anne Mosnier, Brigitte Autran, et al.
Journal of Hepatology|February 14, 2012
Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfectionSawsan Harfouch, Marguerite Guiguet, Marc-Antoine Valantin, et al.
AIDS (London, England)|August 28, 2009
Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virusAurélie Schnuriger, Stéphanie Dominguez, Marguerite Guiguet, et al.
Plos One|May 17, 2012
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individualsJulianna Lisziewicz, Nyasha Bakare, Sandra A Calarota, et al.
Blood|November 15, 2007
Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cellsAmélie Guihot, Eric Oksenhendler, Lionel Galicier, et al.
AIDS (London, England)|March 29, 2017
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumabGwenaëlle Le Garff, Assia Samri, Sidonie Lambert-Niclot, et al.
AIDS (London, England)|March 7, 2013
MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infectionGuillemette Antoni, Julien Guergnon, Céline Meaudre, et al.
Blood|September 28, 2013
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individualsChristina Psomas, Jean-Philippe Lavigne, Claudine Barbuat, et al.
AIDS (London, England)|January 6, 2016
Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoirRuxandra Calin, Chiraz Hamimi, Sidonie Lambert-Niclot, et al.
Pageof 21

Showing results (91-100 of 201) with videos related to

Sort By:
Pageof 21
Oncotarget|March 8, 2016
Perspectives for immunotherapy: which applications might achieve an HIV functional cure?Vincent Vieillard, Shahin Gharakhanian, Olivier Lucar, et al.
Presse Medicale (Paris, France : 1983)|May 8, 2012
[The French Committee for the prevention and control of influenza and the 2009 influenza pandemic: Lessons learnt]Jean-Claude Manuguerra, Anne Mosnier, Brigitte Autran, et al.
Journal of Hepatology|February 14, 2012
Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfectionSawsan Harfouch, Marguerite Guiguet, Marc-Antoine Valantin, et al.
AIDS (London, England)|August 28, 2009
Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virusAurélie Schnuriger, Stéphanie Dominguez, Marguerite Guiguet, et al.
Plos One|May 17, 2012
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individualsJulianna Lisziewicz, Nyasha Bakare, Sandra A Calarota, et al.
Blood|November 15, 2007
Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cellsAmélie Guihot, Eric Oksenhendler, Lionel Galicier, et al.
AIDS (London, England)|March 29, 2017
Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumabGwenaëlle Le Garff, Assia Samri, Sidonie Lambert-Niclot, et al.
AIDS (London, England)|March 7, 2013
MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infectionGuillemette Antoni, Julien Guergnon, Céline Meaudre, et al.
Blood|September 28, 2013
Maraviroc-induced decrease in circulating bacterial products is not linked to an increase in immune activation in HIV-infected individualsChristina Psomas, Jean-Philippe Lavigne, Claudine Barbuat, et al.
AIDS (London, England)|January 6, 2016
Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoirRuxandra Calin, Chiraz Hamimi, Sidonie Lambert-Niclot, et al.
Pageof 21